Manufacturers Life Insurance Company, The Mersana Therapeutics, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $100 Billion
- Q1 2025
A detailed history of Manufacturers Life Insurance Company, The transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 17,374 shares of MRSN stock, worth $5,733. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,374
Previous 43,990
60.5%
Holding current value
$5,733
Previous $62,000
91.94%
% of portfolio
0.0%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding MRSN
# of Institutions
116Shares Held
101MCall Options Held
16.3KPut Options Held
13K-
Nextech Invest Ag12.1MShares$3.98 Million3.22% of portfolio
-
Nextech Invest, Ltd. Zurich, V812.1MShares$3.98 Million0.97% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA8.66MShares$2.86 Million0.99% of portfolio
-
Black Rock Inc. New York, NY8.38MShares$2.77 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.38MShares$2.76 Million0.0% of portfolio
About Mersana Therapeutics, Inc.
- Ticker MRSN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,169,296
- Market Cap $32.1M
- Description
- Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...